2004
DOI: 10.1016/j.ijpharm.2004.01.022
|View full text |Cite
|
Sign up to set email alerts
|

Design of a dissolution system for the evaluation of the release rate characteristics of artemether and dihydroartemisinin from tablets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 13 publications
1
13
0
Order By: Relevance
“…AZ aqueous solubility (39 g L −1 at pH 7.4 and 37 °C (Pfizer, 2013)) was not limiting regarding the dose considered (421 mg AZ dihydrate). In contrast, artemisinin derivatives are characterized by their low aqueous solubility: 0.296 g L −1 (Kauss et al, 2010) and 0.161 g L −1 (Gabriëls & Plaizier-Vercammen, 2004) for AS and AM respectively at 37 °C. For dosage forms containing 300 mg of an artemisinin derivative, this solubility was insufficient to meet solubility (ideally sink, i.e.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…AZ aqueous solubility (39 g L −1 at pH 7.4 and 37 °C (Pfizer, 2013)) was not limiting regarding the dose considered (421 mg AZ dihydrate). In contrast, artemisinin derivatives are characterized by their low aqueous solubility: 0.296 g L −1 (Kauss et al, 2010) and 0.161 g L −1 (Gabriëls & Plaizier-Vercammen, 2004) for AS and AM respectively at 37 °C. For dosage forms containing 300 mg of an artemisinin derivative, this solubility was insufficient to meet solubility (ideally sink, i.e.…”
Section: Resultsmentioning
confidence: 99%
“…The addition of 1% w/v of SLS to the buffer at pH 7 was necessary to obtain requested AM solubility, but this changed the dissolution rate (drug release was slower for both AM and AZ) as a consequence of the increased viscosity of the medium. The Gabriëls and Plaizier-Vercammen (2004) octanol–buffer biphasic system was adopted as the best compromise between physiological conditions and pharmacopoeia specifications. Of note, as this method required that each sample was treated individually, the variance of results was inherently higher than in a conventional monophasic dissolution assay.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…96 Similarly, dihydroartemisin (DHA) is susceptible to light, heat and oxygen due to its peroxy bond and has low bioavailability for oral administration. 97 DHA-loaded MPEG5000-PLLA3200 amphiphilic block copolymeric micelles were devised using modified solvent evaporation method. Nanomicelles had mean sizes below 130 nm.…”
Section: Encapsulation Of Selected Phytochemicalsmentioning
confidence: 99%
“…2 The mechanisms of action for their antitumor activities are not fully understood, but it might be due to transferrin conjugates. Also, DHA has low bioavailability for oral administration, 6 due to its poor water solubility (0.168 mg mL À1 at 30 C). 4,5 However, DHA is susceptible to light, heat, and oxygen for its special peroxy bond.…”
Section: Introductionmentioning
confidence: 99%